Monoclonal Antibodies against Nucleophosmin Mutants: Potentials for the Detection of Acute Myeloid Leukemia
<p>Nucleophosmin (<i>NPM1</i>) gene mutations resulting in cytoplasmic delocalization of Nucleophosmin (NPMc+) are the most common genetic alteration in acute myeloid leukemia (AML). Here, we attempted to prepare monoclonal antibodies (mAbs) against <i>NPM1 </i>mutation...
Main Author: | Shi Tan, Ling Zhang, Xiao-Ming Zhong, Zai-Lin Yang, Liu-Yang Zhao, Yu-Jie Gao, Hui-Yuan Shao, Feng-Xian Qin, Xian-Chun Chen, Hui-Juan Zhang, Hui Chen, Li Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2011-01-01
|
Series: | International Journal of Medical Sciences |
Online Access: | http://www.medsci.org/v08p0309.htm |
Similar Items
-
Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
by: Jabra Zarka, et al.
Published: (2020-06-01) -
Nucleophosmin 1 expression in acute myeloid leukemia
by: Mohammad Davoudi, et al.
Published: (2015-10-01) -
Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia?
by: Mattsson, G, et al.
Published: (2010) -
Detection of nucleophosmin and FMS-like tyrosine kinase-3 gene mutations in acute myeloid leukemia
by: Pazhakh Vahid, et al.
Published: (2011-01-01) -
Incidence and clinical significance of FLT3 and nucleophosmin mutation in childhood acute myeloid leukemia in Chile
by: Maria Elena Cabrera, et al.
Published: (2023-01-01)